|
English
|
正體中文
|
简体中文
|
2823024
|
|
???header.visitor??? :
30207516
???header.onlineuser??? :
378
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"wasan hs"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
國家衛生研究院 |
2020-02 |
Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study
|
Valle, JW;Bai, LY;Orlova, R;Van Cutsem, E;Alfonso, JA;Chen, LT;Obermannova, R;Ettrich, TJ;Chen, JS;Wasan, HS;Denlinger, CS;Vogel, A;He, AR;Bousmans, N;Girvan, AC;Zhang, W;Walgren, RA;Carlesi, R;Oh, DY |
Showing items 1-1 of 1 (1 Page(s) Totally) 1 View [10|25|50] records per page
|